EHA 2026: Flux2Target Helps Identify Metabolic Vulnerabilities and Potential Drug Targets in AML
At EHA 2026, Buddika Jayasingha, PhD student at the University of Eastern Finland, presents Flux2Target, a toolkit for exploring metabolic activity patterns from bulk and single-cell transcriptomic data. Using AML as a case study, the framework combines metabolic flux analysis, interactive visualization, knowledge graphs, and AI-assisted literature exploration to identify metabolic vulnerabilities and prioritize potential drug targets.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in







